Serum Levels of Methyl Methacrylate Following Inhalational Exposure to Polymethylmethacrylate Bone Cement
- Kelly Cornett Homlar(corresponding author),
- Meredith H. Sellers,
- Jennifer L. Halpern,
- Erin H. Seeley,
- Ginger E. Holt
- ,
- Medical Center East,
- Vanderbilt University
Open access
Abstract
Teratogenic effects of polymethylmethacrylate cement at levels used during routine orthopaedic procedures have never been reported, however the hypothetical risk remains a major concern among female surgeons. Our aim was to determine if methyl methacrylate is detectible in the serum during routine cement exposure. Methods: Twenty healthy volunteers were exposed during the mixing of polymethylmethacrylate cement in a simulated operating room environment. Forty serum samples were obtained during the expected peak inhalational exposure and levels of methyl methacrylate were assessed utilizing headspace gas chromatography mass spectrometry. Results: Methyl methacrylate was not detected in any of the forty experimental specimens. Conclusions: With a detection level of 0.5 ppm, methyl methacrylate is undetectable in the serum during routine mixing of polymethylmethacrylate cement.
Publication Information
Output type
Original language
English (US)Pages from-to (Number of pages)
Pages 406-409 (4 pages)Journal (Volume, Issue Number)
Journal of Arthroplasty (Volume 28, Issue 3)Publication milestones
- Published - 03/2013
Publication status
ISSN
0883-5403Publication IDs
- Scopus: 84874562167
- PubMed: 23245392
